This document provides methods and materials related to treating trinucleotide repeat conditions. For example, methods and materials for treating a trinucleotide repeat condition as well as methods and materials for identifying OGG1 polypeptide inhibitors that can be used to treat a trinucleotide repeat condition are provided.